CJC-1295 with DAC 5mg

$90.00

CJC-1295 (with DAC) is a synthetic growth hormone–releasing hormone (GHRH) analogue studied for its extended half-life and sustained stimulation of growth hormone secretion in laboratory research.

This product is for research use only and is intended solely for in vitro experiments. It must not be used in clinical trials involving humans, administered to humans as part of any experiment or investigation, or supplied to any party for human investigational use.

Product Description:

CJC-1295 (with Drug Affinity Complex, DAC) is a modified synthetic analogue of growth hormone–releasing hormone (GHRH) designed to extend its half-life through binding to serum albumin. In research settings, it is investigated for its prolonged ability to stimulate growth hormone release from the pituitary gland.

It is commonly studied in relation to endocrine function, metabolic regulation, and growth hormone signaling pathways. Due to the DAC modification, it demonstrates a longer duration of action compared to non-DAC variants, making it suitable for studies focused on sustained hormonal release profiles.

This product is supplied as a high-purity, lyophilised (freeze-dried) peptide, intended strictly for in vitro and controlled laboratory research applications. Each vial is manufactured under strict quality control standards to ensure consistency and reliability.

Key Details:

Parameter	Details
Chemical Formula	C152H252N44O42
Molecular Mass	~3367.9 Da
CAS Number	863288-34-0
Vial Size	5 mg
Vial Contents	Lyophilized Powder

DISCLAIMER:
All products sold by BionLabs are supplied strictly for laboratory, scientific, and research use only. Not for human consumption. By purchasing, you confirm you are 18+ and authorised to handle these products for lawful research purposes only.